URZAD MARSZALKOWSKI WOJEWODZTWA DOLNOSLASKIEGO

Their core work

The Marshal's Office of Lower Silesia Voivodeship is the executive body of one of Poland's most industrially and scientifically active regions, responsible for managing EU structural funds, designing regional smart specialisation strategies, and coordinating cross-border development initiatives. In H2020, they bring the institutional weight of a regional government: access to public funding streams, formal authority over regional investment priorities, and the ability to translate research outputs into policy decisions and structural fund allocations. Their participation in health-related projects reflects Lower Silesia's designated specialisation in health technologies and personalised medicine — areas where the region has committed political and financial backing. They are not a research body; their value to a consortium is institutional credibility, policy influence, and the ability to embed research results into regional governance and EU co-funded programs.

What they specialise in

How they've shifted over time

Both projects began in 2018, so there is no meaningful early-vs-late split in timelines. However, the keyword profile tells a clear story about the two different roles they played: UPRIGHT (no keywords indexed) represents their contribution as a regional implementer for a public health intervention in schools, while REGIONS4PERMED surfaces the more politically substantive work — interregional cooperation, smart specialisation, structural fund alignment, and technical dialogue on personalised medicine adoption. The pattern suggests a move from passive participation in applied health interventions toward active engagement in the policy architecture of personalised medicine across European regions. If this trajectory continues, their future projects are likely to sit at the intersection of health technology policy, EU cohesion funding, and regional innovation governance rather than in direct clinical or research roles.

They are positioning Lower Silesia as a policy-active region in personalised health, using H2020 participation to connect regional structural fund strategy with pan-European health innovation networks — a trajectory that makes them a useful partner for projects needing formal regional government buy-in and EU co-funding pathways.

How they like to work

They have participated exclusively as consortium partners, never taking on a coordinating role — consistent with how regional public authorities typically engage in H2020: contributing institutional context and policy reach rather than leading research execution. With 14 unique partners across 7 countries from just 2 projects, they operate in moderately large, diverse consortia. This breadth suggests they are sought as regional policy anchors rather than technical specialists, and that each project brings a fresh set of international collaborators rather than a recurring inner circle.

Their network of 14 partners across 7 countries is notably broad for only two projects, indicating they consistently join large multi-country consortia. The geographic spread reflects both projects' explicitly pan-European coordination mandates.

What sets them apart

Among Polish regional authorities, Lower Silesia is one of the few with a formal smart specialisation commitment in health technologies, giving the Marshal's Office a legitimate policy mandate — not just a symbolic presence — in health innovation projects. What distinguishes them is the combination of structural fund authority, a defined regional S3 in health, and demonstrated willingness to engage in interregional technical dialogue, which is rare among public bodies that often participate in EU projects purely for visibility. A consortium that needs a regional government partner who can actually move money and translate research into funded regional programs should look here first.

Highlights from their portfolio

• REGIONS4PERMED
  A high-relevance policy coordination project running to 2023 that placed the Marshal's Office at the centre of a European network translating personalised medicine research into regional investment decisions — their most strategically significant H2020 engagement.
• UPRIGHT
  Their largest single award (EUR 447,500) and a globally-scoped school mental health resilience program spanning 2018–2021, demonstrating capacity to participate in complex multi-country RIA projects beyond purely administrative roles.